Dabigatran etexilate Enrolling by Invitation Phase N/A Trials for Hemorrhage / Anticoagulant Adverse Reaction / thrombotic events / Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03261284D-dimer to Guide Anticoagulation Therapy in Patients With Atrial Fibrillation